SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple is seeing a sharp sell-off as investors react to management's cautious guidance regarding memory supply constraints and margin pressures. The community is actively debating whether this decline represents a long-term breakdown or a buying opportunity, with many traders focusing on high-volatility 0DTE options and critical support levels around the $300 mark.

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. The firm provides online news services where users can select and rank web content. It also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

Reddit is trending following a significant sell-off despite exceeding earnings expectations, with investors expressing frustration over market manipulation and concerns regarding user growth trends. Community discussion remains polarized, pitting those who view the pullback as a buying opportunity for a high-margin data business against critics who continue to target the platform's moderation policies and long-term sustainability.

Roblox Corp. engages in the provision of online gaming services. Its platform consists of Roblox Client, Roblox Studio, and Roblox Cloud. Roblox Client is an application that allows users to explore 3D digital worlds. Roblox Studio is the toolset that allows developers and creators to build, publish, and operate 3D experiences and other content accessed with Roblox Client. Roblox Cloud includes the services and infrastructure that power the human co-experience platforms. The company was founded by Erik Cassel and David B. Baszucki in March 2004 and is headquartered in San Mateo, CA.

Roblox Corporation - Ordinary Shares - Class A

Roblox Corp.

Roblox is facing intense selling pressure as investors react to a challenging earnings report, highlighted by a surprising decision to withdraw full-year guidance and weakened monetization trends. The community is actively debating whether the double-digit drop represents a generational buying opportunity for the long-term platform ecosystem or a sign of deeper structural decline.

Coinbase Global, Inc. engages in the provision of a trusted platform that serves as a compliant on-ramp to the onchain economy and enables users to engage in a wide variety of activities with their crypto assets in both proprietary and third-party product experiences enabled by access to decentralized applications. It offers consumers primary financial account for the cryptoeconomy, institutions a full-service prime brokerage platform with access to deep pools of liquidity across the crypto marketplace, and developers a suite of products granting access to build onchain. The company was founded by Brian Armstrong and Fred Ernest Ehrsam in May 2012 and is headquartered in New York, NY.

Coinbase Global Inc - Ordinary Shares - Class A

Coinbase Global Inc

Coinbase is facing heightened volatility and intense community debate surrounding its upcoming earnings report and the stalled Clarity Act legislation. Investors remain sharply divided between those positioning for a potential regulatory-driven rally and skeptics who are bracing for further downside amid concerns over weak crypto trading volumes and macro uncertainty.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.

Replimune Group Inc

Replimune Group is seeing extreme volatility as investors weigh a positive FDA advisory committee vote for its melanoma therapy against regulatory concerns regarding data integrity and the potential for long-term commercial hurdles. The community remains sharply divided, with some betting on a short squeeze and successful regulatory path, while others argue the stock faces significant downside risk due to potential dilution, high cash burn, and the company's challenging regulatory history.

Luckin Coffee, Inc. engages in providing food and beverage items, and operates coffee retail stores. It has a pioneered a technology-driven retail network to provide coffee and other products of high quality, high convenience and high affordability to customers. The company manages pick-up stores, relax stores, and delivery kitchens. It also offers tea, snacks, and light meals through its mobile application. The company was founded by Zhi Ya Qian, Fei Yang and Jin Yi Guo on June 16, 2017 and is headquartered in Xiamen, China.

Luckin Coffee Inc - ADR

Luckin Coffee is trending as investors gear up for second-quarter financial results, with significant community speculation focused on potential share buyback activity and the long-term prospects of a future relisting on a major exchange. The conversation is anchored by bullish sentiment surrounding the company's aggressive store expansion and its ability to maintain growth within a competitive consumer market.

Phathom Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel treatments for gastrointestinal diseases. The company was founded by Tadataka Yamada, David Socks, Azmi Nabulsi, Aditya Kohli, and Roger Ulrich on January 9, 2018 and is headquartered in Florham Park, NJ.

Phathom Pharmaceuticals Inc

Phathom Pharmaceuticals is trending as investors digest a recent $130 million public offering, which has sparked mixed reactions as it provides necessary operational capital but dilutes existing shareholders. The community remains highly focused on the company's clear path to profitability in 2026, with many viewing the current price volatility as a potential accumulation opportunity given strong prescription growth and ongoing institutional interest.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is seeing bullish momentum fueled by strong early demand for its newly launched oral Wegovy, with investors actively comparing its prescription growth favorably against competitors. The stock is currently testing key technical resistance levels, with community sentiment shifting as market participants anticipate positive guidance updates and potential pipeline expansion to follow recent international approvals.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is currently drawing heavy trading volume as investors react to robust AI infrastructure spending outlooks from major hyperscalers, which reinforce the sustained demand for GPUs. The community remains deeply divided, with bulls pointing to historical valuation support and capacity constraints as signs of a long-term runway, while bears continue to trade on short-term volatility and speculation regarding institutional position unwinding.

Bausch Health Cos., Inc. engages in the development, manufacture and market of a range of branded, generic and branded generic pharmaceuticals, medical devices and over-the-counter products. It operates through the following segments: Salix, International, Solta Medical, Diversified Products, and Bausch + Lomb. The Salix segment consists of sales in the U.S. of GI products. Sales of the Xifaxan product line. The International segment comprises of sales, except for sales of Bausch + Lomb products and Solta aesthetic medical devices, outside the U.S and Puerto Rico of branded pharmaceutical products, branded generic pharmaceutical and OTC products. The Solta Medical segment refers to global sales of Solta Medical aesthetic medical devices. The Diversified Products segment covers sales in the U.S. of pharmaceutical products in the areas of neurology and certain other therapeutic classes, generic products, ortho dermatologic, and dentistry products. The Bausch + Lomb segment are global sales of Bausch + Lomb vision care, surgical and ophthalmic pharmaceuticals products. The company was founded on March 29, 1994, and is headquartered in Laval, Canada.

Bausch Health Companies Inc

Bausch Health is trending as a major stock for speculative momentum following a recent acquisition and ongoing insider accumulation, which has ignited intense community debate about the company's long-term valuation versus its significant debt burden. Traders are actively discussing the stock's volatility and its potential re-rating if the Bausch + Lomb subsidiary is successfully monetized, while many express skepticism due to the company's turbulent historical performance.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Fundstrat Capital Announces July 2026 Monthly Distribution for the Fundstrat Granny Shots US Large Cap & Income ETF (NYSE: GRNI)

Fundstrat Capital Announces July 2026 Monthly Distribution for the Fundstrat Granny Shots US Large Cap & Income ETF (NYSE: GRNI) Fundstrat Capital Announces July 2026 Monthly Distribution for the Fundstrat Granny Shots US Large Cap & Income ETF (NYSE: GRNI) PR Newswire NEW YORK, July 29, 2026 NEW...

Fundstrat Capital Announces June 2026 Monthly Distribution for the Fundstrat Granny Shots US Large Cap & Income ETF (NYSE: GRNI)

Fundstrat Capital Announces June 2026 Monthly Distribution for the Fundstrat Granny Shots US Large Cap & Income ETF (NYSE: GRNI) Fundstrat Capital Announces June 2026 Monthly Distribution for the Fundstrat Granny Shots US Large Cap & Income ETF (NYSE: GRNI) PR Newswire NEW YORK, June 26, 2026 NEW...

Fundstrat Capital Announces May 2026 Monthly Distribution for the Fundstrat Granny Shots US Large Cap & Income ETF (NYSE: GRNI)

Fundstrat Capital Announces May 2026 Monthly Distribution for the Fundstrat Granny Shots US Large Cap & Income ETF (NYSE: GRNI) Fundstrat Capital Announces May 2026 Monthly Distribution for the Fundstrat Granny Shots US Large Cap & Income ETF (NYSE: GRNI) PR Newswire NEW YORK, May 27, 2026 NEW...

Fundstrat Capital Announces Monthly Distribution for the Fundstrat Granny Shots US Large Cap & Income ETF (NYSE: GRNI)

Fundstrat Capital Announces Monthly Distribution for the Fundstrat Granny Shots US Large Cap & Income ETF (NYSE: GRNI) Fundstrat Capital Announces Monthly Distribution for the Fundstrat Granny Shots US Large Cap & Income ETF (NYSE: GRNI) PR Newswire NEW YORK, March 27, 2026 NEW YORK, March 27, 2026...

Fundstrat Capital Announces February 2026 Rebalance for Granny Shots Small- & Mid-Cap ETF (NYSE: GRNJ)

Fundstrat Capital Announces February 2026 Rebalance for Granny Shots Small- & Mid-Cap ETF (NYSE: GRNJ) Fundstrat Capital Announces February 2026 Rebalance for Granny Shots Small- & Mid-Cap ETF (NYSE...

Tom Lee's Fundstrat Capital Announces February 2026 Rebalance for Granny Shots Large Cap ETFs

Tom Lee's Fundstrat Capital Announces February 2026 Rebalance for Granny Shots Large Cap ETFs Tom Lee's Fundstrat Capital Announces February 2026 Rebalance for Granny Shots Large Cap ETFs PR Newswire...

Tom Lee's Granny Shots ETFs Post Accelerated Growth with Flagship GRNY Surpassing $4 Billion in Assets as GRNI and GRNJ Gain Early Momentum

Tom Lee's Granny Shots ETFs Post Accelerated Growth with Flagship GRNY Surpassing $4 Billion in Assets as GRNI and GRNJ Gain Early Momentum Tom Lee's Granny Shots ETFs Post Accelerated Growth with...

Fundstrat Capital Announces Monthly Distribution for the Fundstrat Granny Shots US Large Cap & Income ETF (NYSE: GRNI) Fundstrat Capital Announces Monthly Distribution for the Fundstrat Granny Shots...

Tom Lee's Fundstrat Capital Expands Granny Shots ETF Lineup-- GRNJ and GRNI Will Begin Trading Today on NYSE Arca

Tom Lee's Fundstrat Capital Expands Granny Shots ETF Lineup-- GRNJ and GRNI Will Begin Trading Today on NYSE Arca Tom Lee's Fundstrat Capital Expands Granny Shots ETF Lineup-- GRNJ and GRNI Will...

Tom Lee's Fundstrat Capital Announces Two New Granny Shots ETFs -- GRNJ and GRNI -- Expected to Soon Commence Trading on NYSE Arca

Tom Lee's Fundstrat Capital Announces Two New Granny Shots ETFs -- GRNJ and GRNI -- Expected to Soon Commence Trading on NYSE Arca Tom Lee's Fundstrat Capital Announces Two New Granny Shots ETFs...

Tidal Trust III - Fundstrat Granny Shots US Large Cap & Income ETF

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Fundamentals

Info

GRNIFundstrat Granny Shots US Large Cap & Income ETF

Fundamentals

Connect Stocktwits to ChatGPT

Latest GRNI News